Activation of the G-Protein-Coupled Receptor 119: A Conformation-Based Hypothesis for Understanding Agonist Response

被引:45
作者
McClure, Kim F. [1 ]
Darout, Etzer [1 ]
Guimaraes, Cristiano R. W. [1 ]
DeNinno, Michael P. [1 ]
Mascitti, Vincent [1 ]
Munchhof, Michael J. [1 ]
Robinson, Ralph P. [1 ]
Kohrt, Jeffrey [1 ]
Harris, Anthony R. [1 ]
Moore, Dianna E. [1 ]
Li, Bryan [1 ]
Samp, Lacey [1 ]
Lefker, Bruce A. [1 ]
Futatsugi, Kentaro [1 ]
Kung, Daniel [1 ]
Bonin, Paul D. [2 ]
Cornelius, Peter [2 ]
Wang, Ruduan [2 ]
Salter, Eben [2 ]
Hornby, Sam [2 ]
Kalgutkar, Amit S. [3 ]
Chen, Yue [3 ]
机构
[1] Pfizer Global Res & Dev, Dept Med Chem, Groton, CT 06340 USA
[2] Pfizer Global Res & Dev, Dept Discovery Biol, Groton, CT 06340 USA
[3] Pfizer Global Res & Dev, Dept Drug Metab & Pharmaceut Sci, Groton, CT 06340 USA
关键词
GPR119; AGONISTS; DISCOVERY; AGENTS; TARGETS; POTENT;
D O I
10.1021/jm200003p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and properties of the bridged piperidine (oxaazabicyclo) compounds 8, 9, and 11 are described. A conformational analysis of these structures is compared with the representative GPR119 ligand 1. These results and the differences in agonist pharmacology are used to formulate a conformation-based hypothesis to understand activation of the GPR119 receptor. We also show for these structures that the agonist pharmacology in rat masks the important differences in human pharmacology.
引用
收藏
页码:1948 / 1952
页数:5
相关论文
共 18 条
[1]   Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? [J].
Bissantz, C ;
Bernard, P ;
Hibert, M ;
Rognan, D .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2003, 50 (01) :5-25
[2]   Novel Pyridylmethylamines as Highly Selective 5-HT1A Superagonists [J].
Bollinger, Stefan ;
Huebner, Harald ;
Heinenmann, Frank W. ;
Meyer, Karsten ;
Gmeiner, Peter .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (19) :7167-7179
[3]   A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release [J].
Chu, Zhi-Liang ;
Carroll, Chris ;
Alfonso, Jean ;
Gutierrez, Veronica ;
He, Hongmei ;
Lucman, Annette ;
Pedraza, Melinda ;
Mondala, Helen ;
Gao, Hui ;
Bagnol, Didier ;
Chen, Ruoping ;
Jones, Robert M. ;
Behan, Dominic P. ;
Leonard, James .
ENDOCRINOLOGY, 2008, 149 (05) :2038-2047
[4]   N-Oleoyldopamine Enhances Glucose Homeostasis through the Activation of GPR119 [J].
Chu, Zhi-Liang ;
Carroll, Chris ;
Chen, Ruoping ;
Alfonso, Jean ;
Gutierrez, Veronica ;
He, Hongmei ;
Lucman, Annette ;
Xing, Charles ;
Sebring, Kristen ;
Zhou, Jinyao ;
Wagner, Brandee ;
Unett, David ;
Jones, Robert M. ;
Behan, Dominic P. ;
Leonard, James .
MOLECULAR ENDOCRINOLOGY, 2010, 24 (01) :161-170
[5]   The synthesis of azabicyclic heterocycles [J].
Darout, Etzer ;
Basak, Arindrajit .
TETRAHEDRON LETTERS, 2010, 51 (22) :2998-3001
[6]   Fatty acid amide signaling molecules [J].
Ezzili, Cyrine ;
Otrubova, Katerina ;
Boger, Dale L. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (20) :5959-5968
[7]   New Nonpeptide-Binding GPCRs as Targets for Diabetes and the Metabolic Syndrome [J].
Fyfe, Matthew C. T. ;
Overton, Hilary A. ;
Procter, Martin J. ;
Reynet, Christine ;
White, Jonathan R. .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42, 2007, 42 :129-145
[8]   GPR119 agonists as potential new oral agents for the treatment of type 2 diabetes and obesity [J].
Fyfe, Matthew C. T. ;
McCormack, James G. ;
Overton, Hilary A. ;
Procter, Martin J. ;
Reynet, Christine .
EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (04) :403-413
[9]  
Jones R. M., 2007, [No title captured], Patent No. [WO 2007035355, 2007035355]
[10]   The Emergence of GPR119 Agonists as Anti-Diabetic Agents [J].
Jones, Robert M. ;
Leonard, James N. .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 44, 2009, 44 :149-170